FDA, pancreatic cancer and expanded access
Digest more
The advisory panel wasn't convinced that a clinical trial proved that early switching to camizestrant improved long-term survival rates.
A Senate report alleges that Biden administration health officials failed to act on early warning signs of potential COVID-19 vaccine side effects identified by a Food and Drug Administration scientist.
Regeneron is seeing double-digit revenue growth and has more than 50 therapies in its pipeline, making it a good long-term investment.
Multiple GOP-led states are trying to make it harder for women to access mifepristone, a pill used in nearly two-thirds of abortions across the U.S.
A federal appeals court temporarily reinstated a nationwide requirement that abortion pills be obtained in person, undermining access to the method of abortion that has only grown more widespread since the US Supreme Court overturned Roe v.
A new analysis of chemicals in U.S. infant formula found reassuringly low levels of heavy metals, pesticides and other potential contaminants, federal health officials said Wednesday. The review was conducted as part of the Food and Drug Administration’s Operation Stork Speed project — billed as the “largest and most rigorous” to date.